(RTTNews) – Indian shares look set to open on a flat note Monday despite mostly positive cues from global markets.Read More

(RTTNews) – The Indonesia stock market on Friday snapped the two-day slide in which it had dropped almost 80 points or 1.1 percent. Read More

Energy drink company Celsius Holdings (NASDAQ: CELH) has been a phenomenal long-term holding, turning a $10,000 investment into more than $1.7 million Read More

Much of the artificial intelligence (AI) narrative has so far revolved around software platforms and sophisticated pieces of hardware needed Read More

It has been a rough year for Ethereum (CRYPTO: ETH) holders. Up barely 5% year to date, Ethereum’s performance pales Read More

At this time last year, the stock price for Palantir Technologies (NYSE: PLTR) was under $15 per share. As of mid-morning Read More

Artificial intelligence (AI) has played a central role in lifting semiconductor stocks over the past couple of years, which is Read More

The red-hot rally that started in shares of Nvidia (NASDAQ: NVDA) toward the end of 2022 is now almost two years Read More

If you own Boeing (NYSE: BA) stock, you’ve probably been glued to news of the protracted labor strike by Read More

Viking Therapeutics (NASDAQ: VKTX) and Summit Therapeutics (NASDAQ: SMMT) are both up-and-coming biotechs with no sales revenue, plenty of cash Read More

Cryptocurrency is still a relatively new concept, one that the majority of society has not fully adopted. Whether you’ve Read More

Social Security’s wealthiest beneficiaries take in $4,873 per month from the program in 2024. That’s more than $58,000 annually. Some households Read More

Interest in nuclear power is picking up. Last month, 14 of the world’s banks and financial institutions pledged their support Read More

It’s been a very difficult year for Walgreens Boots Alliance (NASDAQ: WBA), which has seen its stock lose two-thirds Read More

In today’s video, I will be talking about the recent updates regarding Palantir (NYSE: PLTR). Check out the short Read More

Media-streaming technology veteran Roku (NASDAQ: ROKU) has plenty of growth catalysts up in the air. The most important and promising Read More

By now, nearly everyone has heard of the weight loss drugs targeted at the glucagon-like protein 1 (GLP-1) receptor, like Zepbound Read More

If there’s one person in finance that almost everybody knows about it’s probably Warren Buffett, the CEO of Read More